Understanding the Role of Rebates in Prescription Drug Pricing

All materials can be found in full at the links provided.

 

Key Resources (listed chronologically, beginning with the most recent)

“As a PBM and an Employer, We Know Rebates and Innovation Lower Drug Costs.” Merlo, L. Morning Consult. October 3, 3018. Available at http://allh.us/xqJp.

“Association of Prescription Drug Price Rebates in Medicare Part D with Patient Out-of-Pocket and Federal Spending.” Dusetzina, S., Conti, R., Yu, N., Bach, P. JAMA Internal Medicine. August 1, 2018. Available at http://allh.us/CyFE.

“Antitrust Implications of HHS Proposal to Limit Manufacturer Rebates.” Barker, T., Margulies, R., Schulwolf, E. Foley Hoag LLP. August 2018. Available at http://allh.us/CndB.

“Meet the Rebate, the New Villain of High Drug Prices.” Thomas, K. New York Times. July 27, 2018. Available at http://allh.us/PkXW.

“A Primer on Prescription Drug Rebates: Insights into Why Rebates Are a Target for Reducing Prices,” Dieguez, G., Alston, M., Tomicki, S. Milliman. May 2018. Available at http://allh.us/FTG8.

‘The Impact of Prescription Drug Rebates on Health Plans and Consumers.” Roehrig, C. Altarum Institute. April 2018. Available at http://allh.us/6XxC.

 

Additional Resources (listed chronologically, beginning with the most recent)

“An Overview of the Medicare Part D Prescription Drug Benefit.” The Henry J. Kaiser Family Foundation. October 2018. Available at http://allh.us/9t4h.

“Drug Rebates Aren’t ‘Kickbacks.’” Antos, J., Capretta, J.C. American Enterprise Institute. September 17, 2018. Available at http://allh.us/Dm6p.

“Pharmaceutical Reference Pricing: Does It Have a Future in the U.S.?” Robinson, J. The Commonwealth Fund. September 2018. Available at http://allh.us/EcFf.

“Eliminating Drug Rebates Requires Complex Solutions.” Brantley, K., Grady, L., Olsen, M., Tiernan, M. Avalere Health. August 16, 2018. Available at http://allh.us/KGrw.

“A System Without Rebates: The Drug Channels Negotiated Discounts Model.” Fein, A. Drug Channels Institute. August 2, 2018. Available at http://allh.us/jaBv.

“Current and New Approaches to Making Drugs More Affordable.” CVS Health Corporation. August 2018. Available at http://allh.us/tHEP.

“Prescription Drug Rebates and Part D Drug Costs: Analysis of Historical Medicare Part D Drug Prices and Manufacturer Rebates.” Johnson, N., Mills, C., Kridgen, M. Milliman. July 16, 2018. Available at http://allh.us/WvMD.

“Premium Impact of Removing Manufacturer Rebates from the Medicare Part D Program.” Fitzpatrick, R., Carlson, C. Oliver Wyman. July 6, 2018. Available at http://allh.us/WkAa.

“Pharmacy Benefit Managers Are Not the Cause of High Prescription Drug Prices.” Brannon, I. The Cato Institute. June 6, 2018. Available at http://allh.us/WVwT.

“Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control.” Young, K., Garfield, R. The Henry J. Kaiser Family Foundation. February 2018. Available at http://allh.us/drtm.

“Rx Pricing Along the Supply Chain.” Altarum Institute. 2018. Available at http://allh.us/nV6F.

“Pharmaceutical Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.” Ge, B., Sen, A., Anderson, G. Annals of Internal Medicine. 2018. Available at http://allh.us/3T7e.

“Primer: Prescription Drug Prices: Discounts, Fees, and Effects on Part D.” O’Neill Hayes, T. American Action Forum. October 2017. Available at http://allh.us/K8VE.

“Increasing Prices Set by Drugmakers Not Correlated With Rebates.” Pharmaceutical Care Management Association. June 2017. Available at http://allh.us/PGtF.

“The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders.” Vandervelde, A., Blalock, E. Berkeley Research Group. January 2017. Available at http://allh.us/8xUR.

“Branded Prescription Drug Spending: A Framework to Evaluate Policy Options.” Ballreich, J., Alexander, C., Socal, M., Karmarkar, T., Anderson, G. Journal of Pharmaceutical Policy and Practice. 2017. Available at http://allh.us/aAJv.

“Reducing Branded Prescription Drug Prices: A Review of Policy Options.” Alexander, C., Ballreich, J., Socal, M., Karmarkar, T., Trujillo, A., Greene, J., Sharfstein, J., Anderson, G. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2017. Available at http://allh.us/KmNv.